Filtros de búsqueda

Lista de obras de Francis W Hunter

Dual targeting of hypoxia and homologous recombination repair dysfunction in triple-negative breast cancer.

artículo científico publicado en 2014

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

artículo científico publicado en 2018

Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide

artículo científico publicado en 2019

Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: comparison with other hypoxia-activated prodrugs.

artículo científico publicado en 2011

Hypoxia-activated prodrugs: paths forward in the era of personalised medicine.

artículo científico publicado en 2016

Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361

artículo científico publicado en 2019

Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs.

artículo científico publicado en 2015

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer

scientific article published on 16 December 2019

Old target; new paradigm: Determinants of sensitivity to hypoxia-directed anticancer prodrugs ⬇️

2014 doctoral thesis by Francis Hunter at University of Auckland

Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia

artículo científico publicado en 2019

The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda